文献速递临床试验与 GCP流行病学与生物统计

择期结直肠手术术前口服抗生素预防严重感染并发症(PreCaution)随机对照试验方案

Prevention of severe infectious complications after colorectal surgery using preoperative orally administered antibiotic prophylaxis (PreCaution): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-01-19

PreCaution试验为多中心、双盲、随机、安慰剂对照研究,计划纳入966例择期结直肠手术成人患者,比较术前3天口服妥布霉素与多粘菌素E联合围手术期静脉抗生素与安慰剂联合静脉抗生素对术后30天内深部手术部位感染和/或死亡率的影响。目前术前口服抗生素作为额外预防的价值缺乏确证证据。

要点

  • 择期结直肠手术患者随机接受术前口服妥布霉素+多粘菌素E或安慰剂,均联合围手术期静脉抗生素。
  • 主要终点为术后30天内深部手术部位感染和/或死亡的累积发生率。
  • 研究旨在明确术前口服抗生素在静脉预防基础上能否进一步减少感染并发症。

核心结论

  • 目前缺乏确证证据支持择期结直肠手术术前口服抗生素作为额外预防的价值,PreCaution试验旨在评估其在静脉抗生素预防基础上减少深部手术部位感染和/或死亡的效果。

研究设计与样本

  • 多中心、双盲、随机、安慰剂对照临床试验,在荷兰开展,计划随机分配966例择期结直肠手术成人患者。
  • 研究药物为妥布霉素和多粘菌素E硫酸盐溶液或安慰剂溶液,术前3天每日四次给药;所有患者按国家感染控制指南接受围手术期静脉抗生素预防。

主要发现

  • 本文为研究方案,未报告试验结果。

关键数值与推荐

  • 主要终点为术后30天内深部手术部位感染和/或死亡的累积发生率。
  • 次要终点包括结直肠手术的感染性和非感染性并发症,于术后30天和/或6个月评估。

临床怎么用

  • 术前口服抗生素目前尚未纳入大多数医院的常规实践;该试验旨在为择期结直肠手术中额外口服抗生素预防提供证据。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Colorectal surgery is frequently complicated by surgical site infections (SSIs). The most important consequences of SSIs are prolonged hospitalization, an increased risk of surgical reintervention and an increase in mortality. Perioperative intravenously administered antibiotic prophylaxis is the standard of care to reduce the risk of SSIs. In the last few decades, preoperative orally administered antibiotics have been suggested as additional prophylaxis to further reduce the risk of infection, but are currently not part of routine practice in most hospitals. The objective of this study is to evaluate the efficacy of a preoperative orally administered antibiotic prophylaxis (Pre-OP) in addition to intravenously administered perioperative antibiotic prophylaxis to reduce the incidence of deep SSIs and/or mortality after elective colorectal surgery. METHODS/DESIGN: The PreCaution trial is designed as a multicenter, double-blind, randomized, placebo-controlled clinical trial that will be carried out in The Netherlands. Adult patients who are scheduled for elective colorectal surgery are eligible to participate. In total, 966 patients will be randomized to receive the study medication. This will either be Pre-OP, a solution that consists of tobramycin and colistin sulphate, or a placebo solution. The study medication will be administered four times daily during the 3 days prior to surgery. Perioperative intravenously administered antibiotic prophylaxis will be administered to all patients in accordance with national infection control guidelines. The primary endpoint of the study is the cumulative incidence of deep SSIs and/or mortality within 30 days after surgery. Secondary endpoints include both infectious and non-infectious complications of colorectal surgery, and will be evaluated 30 days and/or 6 months after surgery. DISCUSSION: To date, conclusive evidence on the added value of preoperative orally administered antibiotic prophylaxis in colorectal surgery is lacking. The PreCaution trial should determine the effects of orally administered antibiotics in preventing infectious complications in elective colorectal surgery. TRIAL REGISTRATION: Netherlands Trial Register, ID: NTR6113 . Registered on 11 October 2016; EudraCT 2015-005736-17.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mulder T, Kluytmans-van den Bergh MFQ, de Smet AMGA, et al. Prevention of severe infectious complications after colorectal surgery using preoperative orally administered antibiotic prophylaxis (PreCaution): study protocol for a randomized controlled trial. Trials. 2018. PMID: 29351789. doi:10.1186/s13063-018-2439-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。